{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:06:11Z","timestamp":1790845571445,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T00:00:00Z","timestamp":1513555200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s00262-017-2106-8","type":"journal-article","created":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T09:31:39Z","timestamp":1513589499000},"page":"537-549","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":89,"title":["IL-6 and IL-10 are associated with good prognosis in early stage invasive breast cancer patients"],"prefix":"10.1007","volume":"67","author":[{"given":"Narmeen","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aula","family":"Ammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Storr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"Rakha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian O.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart G.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,18]]},"reference":[{"issue":"2","key":"2106_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10549-008-9936-1","volume":"113","author":"RA Mohammed","year":"2009","unstructured":"Mohammed RA, Ellis IO, Elsheikh S, Paish EC, Martin SG (2009) Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications. Breast Cancer Res Treat 113(2):261\u2013273. \n                        https:\/\/doi.org\/10.1007\/s10549-008-9936-1","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"2106_CR2","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1038\/modpathol.2014.60","volume":"27","author":"RA Mohammed","year":"2014","unstructured":"Mohammed RA, Menon S, Martin SG, Green AR, Paish EC, Ellis IO (2014) Prognostic significance of lymphatic invasion in lymph node-positive breast carcinoma: findings from a large case series with long-term follow-up using immunohistochemical endothelial marker. Mod Pathol 27(12):1568\u20131577. \n                        https:\/\/doi.org\/10.1038\/modpathol.2014.60","journal-title":"Mod Pathol"},{"issue":"5","key":"2106_CR3","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/bjc.2012.347","volume":"107","author":"ZM Mohammed","year":"2012","unstructured":"Mohammed ZM, Going JJ, Edwards J, Elsberger B, Doughty JC, McMillan DC (2012) The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer. Br J Cancer 107(5):864\u2013873. \n                        https:\/\/doi.org\/10.1038\/bjc.2012.347","journal-title":"Br J Cancer"},{"issue":"3","key":"2106_CR4","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1189\/jlb.1107762","volume":"84","author":"JW Pollard","year":"2008","unstructured":"Pollard JW (2008) Macrophages define the invasive microenvironment in breast cancer. J Leukoc Biol 84(3):623\u2013630. \n                        https:\/\/doi.org\/10.1189\/jlb.1107762","journal-title":"J Leukoc Biol"},{"issue":"6","key":"2106_CR5","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140(6):883\u2013899. \n                        https:\/\/doi.org\/10.1016\/j.cell.2010.01.025","journal-title":"Cell"},{"issue":"9","key":"2106_CR6","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1006\/cyto.1998.0349","volume":"10","author":"KS \u00c1sgeirsson","year":"1998","unstructured":"\u00c1sgeirsson KS, \u00d3lafsd\u00f3ttir K, J\u00f3nasson JG, \u00d6gmundsd\u00f3ttir HM (1998) The effects of IL-6 on cell adhesion and e-cadherin expression in breast cancer. Cytokine 10(9):720\u2013728","journal-title":"Cytokine"},{"issue":"5B","key":"2106_CR7","first-page":"3905","volume":"26","author":"YC Chung","year":"2006","unstructured":"Chung YC, Chaen YL, Hsu CP (2006) Clinical significance of tissue expression of interleukin-6 in colorectal carcinoma. Anticancer Res 26(5B):3905\u20133911","journal-title":"Anticancer Res"},{"issue":"18","key":"2106_CR8","doi-asserted-by":"publisher","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-11-0945","volume":"17","author":"J Coward","year":"2011","unstructured":"Coward J, Kulbe H, Chakravarty P, Leader D, Vassileva V, Leinster DA, Thompson R, Schioppa T, Nemeth J, Vermeulen J, Singh N, Avril N, Cummings J, Rexhepaj E, Jirstrom K, Gallagher WM, Brennan DJ, McNeish IA, Balkwill FR (2011) Interleukin-6 as a therapeutic target in human ovarian cancer. Clin Cancer Res 17(18):6083\u20136096. \n                        https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-0945","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2106_CR9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH633>3.0.CO;2-X","volume":"191","author":"A Hobisch","year":"2000","unstructured":"Hobisch A, Rogatsch H, Hittmair A, Fuchs D, Bartsch G Jr, Klocker H, Bartsch G, Culig Z (2000) Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue. J Pathol 191(3):239\u2013244","journal-title":"J Pathol"},{"issue":"9","key":"2106_CR10","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1002\/(SICI)1097-0142(20000501)88:9<2061::AID-CNCR12>3.0.CO;2-O","volume":"88","author":"A Karczewska","year":"2000","unstructured":"Karczewska A, Nawrocki S, Breborowicz D, Filas V, Mackiewicz A (2000) Expression of interleukin-6, interleukin-6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma. Cancer 88(9):2061\u20132071","journal-title":"Cancer"},{"issue":"16","key":"2106_CR11","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1158\/0008-5472.CAN-14-3042","volume":"75","author":"Z Qu","year":"2015","unstructured":"Qu Z, Sun F, Zhou J, Li L, Shapiro SD, Xiao G (2015) Interleukin-6 prevents the Initiation but enhances the progression of lung cancer. Cancer Res 75(16):3209\u20133215. \n                        https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-3042","journal-title":"Cancer Res"},{"issue":"1","key":"2106_CR12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/ijc.2910550118","volume":"55","author":"GA Gastl","year":"1993","unstructured":"Gastl GA, Abrams JS, Nanus DM, Oosterkamp R, Silver J, Liu F, Chen M, Albino AP, Bander NH (1993) Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int J Cancer 55(1):96\u2013101","journal-title":"Int J Cancer"},{"issue":"2","key":"2106_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cellimm.2010.09.010","volume":"266","author":"MC Heckel","year":"2011","unstructured":"Heckel MC, Wolfson A, Slachta CA, Schwarting R, Salgame P, Katsetos CD, Platsoucas CD (2011) Human breast tumor cells express IL-10 and IL-12p40 transcripts and proteins, but do not produce IL-12p70. Cell Immunol 266(2):143\u2013153. \n                        https:\/\/doi.org\/10.1016\/j.cellimm.2010.09.010","journal-title":"Cell Immunol"},{"issue":"6","key":"2106_CR14","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/modpathol.2011.5","volume":"24","author":"E Itakura","year":"2011","unstructured":"Itakura E, Huang RR, Wen DR, Paul E, Wunsch PH, Cochran AJ (2011) IL-10 expression by primary tumor cells correlates with melanoma progression from radial to vertical growth phase and development of metastatic competence. Mod Pathol 24(6):801\u2013809. \n                        https:\/\/doi.org\/10.1038\/modpathol.2011.5","journal-title":"Mod Pathol"},{"issue":"2","key":"2106_CR15","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1684\/ecn.2010.0188","volume":"21","author":"A Rabinovich","year":"2010","unstructured":"Rabinovich A, Medina L, Piura B, Huleihel M (2010) Expression of IL-10 in human normal and cancerous ovarian tissues and cells. Eur Cytokine Netw 21(2):122\u2013128. \n                        https:\/\/doi.org\/10.1684\/ecn.2010.0188","journal-title":"Eur Cytokine Netw"},{"issue":"6","key":"2106_CR16","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/bjc.1994.469","volume":"70","author":"S Kruger-Krasagakes","year":"1994","unstructured":"Kruger-Krasagakes S, Krasagakis K, Garbe C, Schmitt E, Huls C, Blankenstein T, Diamantstein T (1994) Expression of interleukin 10 in human melanoma. Br J Cancer 70(6):1182\u20131185","journal-title":"Br J Cancer"},{"issue":"11","key":"2106_CR17","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.4049\/jimmunol.168.11.5397","volume":"168","author":"K Wolk","year":"2002","unstructured":"Wolk K, Kunz S, Asadullah K, Sabat R (2002) Cutting edge: immune cells as sources and targets of the IL-10 family members? J Immunol 168(11):5397\u20135402","journal-title":"J Immunol"},{"issue":"6","key":"2106_CR18","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/CCO.0000000000000006","volume":"25","author":"KL Dennis","year":"2013","unstructured":"Dennis KL, Blatner NR, Gounari F, Khazaie K (2013) Current status of interleukin-10 and regulatory T cells in cancer. Curr Opin Oncol 25(6):637\u2013645. \n                        https:\/\/doi.org\/10.1097\/CCO.0000000000000006","journal-title":"Curr Opin Oncol"},{"issue":"8","key":"2106_CR19","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1002\/ijc.21598","volume":"118","author":"T Sakamoto","year":"2006","unstructured":"Sakamoto T, Saito H, Tatebe S, Tsujitani S, Ozaki M, Ito H, Ikeguchi M (2006) Interleukin-10 expression significantly correlates with minor CD8 + T cell infiltration and high microvessel density in patients with gastric cancer. Int J Cancer 118(8):1909\u20131914. \n                        https:\/\/doi.org\/10.1002\/ijc.21598","journal-title":"Int J Cancer"},{"issue":"5","key":"2106_CR20","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1074\/jbc.M112.386573","volume":"288","author":"DA Braun","year":"2013","unstructured":"Braun DA, Fribourg M, Sealfon SC (2013) Cytokine response is determined by duration of receptor and signal transducers and activators of transcription 3 (STAT3) activation. J Biol Chem 288(5):2986\u20132993. \n                        https:\/\/doi.org\/10.1074\/jbc.M112.386573","journal-title":"J Biol Chem"},{"issue":"1","key":"2106_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0002-9440(10)63271-3","volume":"165","author":"RE Nisato","year":"2004","unstructured":"Nisato RE, Harrison JA, Buser R, Orci L, Rinsch C, Montesano R, Dupraz P, Pepper MS (2004) Generation and characterization of telomerase-transfected human lymphatic endothelial cells with an extended life span. Am J Pathol 165(1):11\u201324. \n                        https:\/\/doi.org\/10.1016\/S0002-9440(10)63271-3","journal-title":"Am J Pathol"},{"issue":"4","key":"2106_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1089\/lrb.2012.0007","volume":"10","author":"S Safuan","year":"2012","unstructured":"Safuan S, Storr SJ, Patel PM, Martin SG (2012) A comparative study of adhesion of melanoma and breast cancer cells to blood and lymphatic endothelium. Lymphat Res Biol 10(4):173\u2013181. \n                        https:\/\/doi.org\/10.1089\/lrb.2012.0007","journal-title":"Lymphat Res Biol"},{"issue":"4","key":"2106_CR23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/sj.bjc.6602678","volume":"93","author":"LM McShane","year":"2005","unstructured":"McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM (2005) REporting recommendations for tumour MARKer prognostic studies (REMARK). Br J Cancer 93(4):387\u2013391. \n                        https:\/\/doi.org\/10.1038\/sj.bjc.6602678","journal-title":"Br J Cancer"},{"issue":"15","key":"2106_CR24","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1200\/JCO.2010.30.5037","volume":"29","author":"SM Mahmoud","year":"2011","unstructured":"Mahmoud SM, Paish EC, Powe DG, Macmillan RD, Grainge MJ, Lee AH, Ellis IO, Green AR (2011) Tumor-infiltrating CD8 + lymphocytes predict clinical outcome in breast cancer. J Clin Oncol 29(15):1949\u20131955. \n                        https:\/\/doi.org\/10.1200\/JCO.2010.30.5037","journal-title":"J Clin Oncol"},{"issue":"30","key":"2106_CR25","doi-asserted-by":"publisher","first-page":"47927","DOI":"10.18632\/oncotarget.10066","volume":"7","author":"SJ Storr","year":"2016","unstructured":"Storr SJ, Zhang S, Perren T, Lansdown M, Fatayer H, Sharma N, Gahlaut R, Shaaban A, Martin SG (2016) The calpain system is associated with survival of breast cancer patients with large but operable inflammatory and non-inflammatory tumours treated with neoadjuvant chemotherapy. Oncotarget 7(30):47927\u201347937. \n                        https:\/\/doi.org\/10.18632\/oncotarget.10066","journal-title":"Oncotarget"},{"issue":"21","key":"2106_CR26","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10(21):7252\u20137259. \n                        https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-0713","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2106_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10549-016-3709-z","volume":"156","author":"MA Aleskandarany","year":"2016","unstructured":"Aleskandarany MA, Agarwal D, Negm OH, Ball G, Elmouna A, Ashankyty I, Nuglozeh E, Fazaludeen MF, Diez-Rodriguez M, Nolan CC, Tighe PJ, Green AR, Ellis IO, Rakha EA (2016) The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts. Breast Cancer Res Treat 156(1):9\u201320. \n                        https:\/\/doi.org\/10.1007\/s10549-016-3709-z","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"2106_CR28","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1158\/1078-0432.CCR-08-2132","volume":"15","author":"EA Rakha","year":"2009","unstructured":"Rakha EA, Elsheikh SE, Aleskandarany MA, Habashi HO, Green AR, Powe DG, El-Sayed ME, Benhasouna A, Brunet JS, Akslen LA, Evans AJ, Blamey R, Reis-Filho JS, Foulkes WD, Ellis IO (2009) Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes. Clin Cancer Res 15(7):2302\u20132310. \n                        https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-2132","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2106_CR29","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1186\/bcr1648","volume":"9","author":"C Chavey","year":"2007","unstructured":"Chavey C, Bibeau F, Gourgou-Bourgade S, Burlinchon S, Boissiere F, Laune D, Roques S, Lazennec G (2007) Oestrogen receptor negative breast cancers exhibit high cytokine content. Breast Cancer Res 9(1):R15. \n                        https:\/\/doi.org\/10.1186\/bcr1648","journal-title":"Breast Cancer Res"},{"issue":"3\u20134","key":"2106_CR30","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/sj.bjc.6690394","volume":"80","author":"G Fontanini","year":"1999","unstructured":"Fontanini G, Campani D, Roncella M, Cecchetti D, Calvo S, Toniolo A, Basolo F (1999) Expression of interleukin 6 (IL-6) correlates with oestrogen receptor in human breast carcinoma. Br J Cancer 80(3\u20134):579\u2013584. \n                        https:\/\/doi.org\/10.1038\/sj.bjc.6690394","journal-title":"Br J Cancer"},{"issue":"4","key":"2106_CR31","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.breast.2005.09.012","volume":"15","author":"L Llanes-Fernandez","year":"2006","unstructured":"Llanes-Fernandez L, Alvarez-Goyanes RI, Arango-Prado Mdel C, Alcocer-Gonzalez JM, Mojarrieta JC, Perez XE, Lopez MO, Odio SF, Camacho-Rodriguez R, Guerra-Yi ME, Madrid-Marina V, Tamez-Guerra R, Rodriguez-Padilla C (2006) Relationship between IL-10 and tumor markers in breast cancer patients. Breast 15(4):482\u2013489. \n                        https:\/\/doi.org\/10.1016\/j.breast.2005.09.012","journal-title":"Breast"},{"issue":"1","key":"2106_CR32","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s00595-009-4016-7","volume":"40","author":"Y Toiyama","year":"2010","unstructured":"Toiyama Y, Miki C, Inoue Y, Minobe S, Urano H, Kusunoki M (2010) Loss of tissue expression of interleukin-10 promotes the disease progression of colorectal carcinoma. Surg Today 40(1):46\u201353. \n                        https:\/\/doi.org\/10.1007\/s00595-009-4016-7","journal-title":"Surg Today"},{"issue":"8","key":"2106_CR33","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1093\/carcin\/bgw062","volume":"37","author":"B Fernandez-Garcia","year":"2016","unstructured":"Fernandez-Garcia B, Eiro N, Miranda MA, Cid S, Gonzalez LO, Dominguez F, Vizoso FJ (2016) Prognostic significance of inflammatory factors expression by stroma from breast carcinomas. Carcinogenesis 37(8):768\u2013776. \n                        https:\/\/doi.org\/10.1093\/carcin\/bgw062","journal-title":"Carcinogenesis"},{"issue":"3","key":"2106_CR34","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF02967464","volume":"7","author":"K Arihiro","year":"2000","unstructured":"Arihiro K, Oda H, Kaneko M, Inai K (2000) Cytokines facilitate chemotactic motility of breast carcinoma cells. Breast Cancer 7(3):221\u2013230","journal-title":"Breast Cancer"},{"issue":"7","key":"2106_CR35","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1593\/neo.13706","volume":"15","author":"Q Chang","year":"2013","unstructured":"Chang Q, Bournazou E, Sansone P, Berishaj M, Gao SP, Daly L, Wels J, Theilen T, Granitto S, Zhang X, Cotari J, Alpaugh ML, de Stanchina E, Manova K, Li M, Bonafe M, Ceccarelli C, Taffurelli M, Santini D, Altan-Bonnet G, Kaplan R, Norton L, Nishimoto N, Huszar D, Lyden D, Bromberg J (2013) The IL-6\/JAK\/Stat3 feed-forward loop drives tumorigenesis and metastasis. Neoplasia 15(7):848\u2013862","journal-title":"Neoplasia"},{"issue":"8","key":"2106_CR36","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/carcin\/bgn164","volume":"29","author":"T \u010ca\u010dev","year":"2008","unstructured":"\u010ca\u010dev T, Rado\u0161evi\u0107 S, Kri\u017eanac \u0160, Kapitanovi\u0107 S (2008) Influence of interleukin-8 and interleukin-10 on sporadic colon cancer development and progression. Carcinogenesis 29(8):1572\u20131580","journal-title":"Carcinogenesis"},{"issue":"8","key":"2106_CR37","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/jnci\/88.8.536","volume":"88","author":"N Kundu","year":"1996","unstructured":"Kundu N, Beaty TL, Jackson MJ, Fulton AM (1996) Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer. J Natl Cancer Inst 88(8):536\u2013541","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"2106_CR38","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.ccr.2011.11.003","volume":"20","author":"JB Mumm","year":"2011","unstructured":"Mumm JB, Emmerich J, Zhang X, Chan I, Wu L, Mauze S, Blaisdell S, Basham B, Dai J, Grein J, Sheppard C, Hong K, Cutler C, Turner S, LaFace D, Kleinschek M, Judo M, Ayanoglu G, Langowski J, Gu D, Paporello B, Murphy E, Sriram V, Naravula S, Desai B, Medicherla S, Seghezzi W, McClanahan T, Cannon-Carlson S, Beebe AM, Oft M (2011) IL-10 elicits IFNgamma-dependent tumor immune surveillance. Cancer Cell 20(6):781\u2013796. \n                        https:\/\/doi.org\/10.1016\/j.ccr.2011.11.003","journal-title":"Cancer Cell"},{"key":"2106_CR39","doi-asserted-by":"publisher","first-page":"24249","DOI":"10.1038\/srep24249","volume":"6","author":"S Wang","year":"2016","unstructured":"Wang S, Gao X, Shen G, Wang W, Li J, Zhao J, Wei YQ, Edwards CK (2016) Interleukin-10 deficiency impairs regulatory T cell-derived neuropilin-1 functions and promotes Th1 and Th17 immunity. Sci Rep 6:24249. \n                        https:\/\/doi.org\/10.1038\/srep24249","journal-title":"Sci Rep"},{"issue":"4","key":"2106_CR40","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.immuni.2011.01.020","volume":"34","author":"S Huber","year":"2011","unstructured":"Huber S, Gagliani N, Esplugues E, O\u2019Connor W Jr, Huber FJ, Chaudhry A, Kamanaka M, Kobayashi Y, Booth CJ, Rudensky AY, Roncarolo MG, Battaglia M, Flavell RA (2011) Th17 cells express interleukin-10 receptor and are controlled by Foxp3(\u2212) and Foxp3 + regulatory CD4 + T cells in an interleukin-10-dependent manner. Immunity 34(4):554\u2013565. \n                        https:\/\/doi.org\/10.1016\/j.immuni.2011.01.020","journal-title":"Immunity"},{"issue":"11","key":"2106_CR41","doi-asserted-by":"publisher","first-page":"e49047","DOI":"10.1371\/journal.pone.0049047","volume":"7","author":"N Eiro","year":"2012","unstructured":"Eiro N, Gonzalez L, Gonzalez LO, Fernandez-Garcia B, Lamelas ML, Marin L, Gonzalez-Reyes S, del Casar JM, Vizoso FJ (2012) Relationship between the inflammatory molecular profile of breast carcinomas and distant metastasis development. PLoS ONE 7(11):e49047. \n                        https:\/\/doi.org\/10.1371\/journal.pone.0049047","journal-title":"PLoS ONE"},{"issue":"5","key":"2106_CR42","first-page":"454","volume":"7","author":"M Kate ten","year":"2006","unstructured":"ten Kate M, Hofland LJ, van Koetsveld PM, Jeekel J, van Eijck CH (2006) Pro-inflammatory cytokines affect pancreatic carcinoma cell. Endothel Cell Interact JOP 7(5):454\u2013464","journal-title":"Endothel Cell Interact JOP"},{"issue":"5","key":"2106_CR43","first-page":"517","volume":"30","author":"Y Li","year":"2014","unstructured":"Li Y, Yu H, Jiao S, Yang J (2014) Prognostic value of IL-10 expression in tumor tissues of breast cancer patients. Xi bao yu fen zi mian yi xue za zhi 30(5):517\u2013520 (article Chinese)","journal-title":"Xi bao yu fen zi mian yi xue za zhi"},{"issue":"7","key":"2106_CR44","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1023\/A:1008375208574","volume":"11","author":"H Hatanaka","year":"2000","unstructured":"Hatanaka H, Abe Y, Kamiya T, Morino F, Nagata J, Tokunaga T, Oshika Y, Suemizu H, Kijima H, Tsuchida T (2000) Clinical implications of interleukin (IL)-10 induced by non-small-cell lung cancer. Ann Oncol 11(7):815\u2013819","journal-title":"Ann Oncol"},{"issue":"2","key":"2106_CR45","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0014-5793(00)02296-1","volume":"486","author":"T Yamamoto","year":"2000","unstructured":"Yamamoto T, Matsuda T, Junicho A, Kishi H, Saatcioglu F, Muraguchi A (2000) Cross-talk between signal transducer and activator of transcription 3 and estrogen receptor signaling. FEBS Lett 486(2):143\u2013148","journal-title":"FEBS Lett"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-017-2106-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-017-2106-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-017-2106-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T08:03:30Z","timestamp":1521533010000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-017-2106-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,18]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["2106"],"URL":"https:\/\/doi.org\/10.1007\/s00262-017-2106-8","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,18]]}}}